And I must say, Adapt/Cardiocel is the king here as I've said all along. It's been said the sp gains have came on HSV announcements and to an extent this may be true, key word may but Im in for Cardiocel for it's proven success and after the sp not going anywhere on the best HSV announcement the company has ever seen, I'm sure now a lot will realise that it's just could possibly be Cardiocel that long term buyers buy in for a send the sp north :)
updated ballieu report - target range 25-55c, page-31
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.17 |
Change
-0.230(1.49%) |
Mkt cap ! $319.3M | |||
| Open | High | Low | Value | Volume |
| $15.15 | $15.39 | $15.00 | $103.1K | 6.823K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4 | $15.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 147 | 3 |
View Market Depth
| Last trade - 15.11pm 22/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |